Treating Alzheimer’s patients with TPS: What is TPS?

In 2018, Transcranial Pulse Stimulation (TPS®) with the NEUROLITH® system was the first, and hitherto only, procedure of its kind to obtain market authorization for the »treatment of the central nervous system of patients with Alzheimer’s disease«. The aim of TPS® is to boost the cognitive abilities of people with Alzheimer’s dementia by stimulating various regions of the brain and to maintain these abilities for as long as possible. 

TPS® was developed in collaboration with researchers from the Medical University of Vienna (Department of Neurology), led by Prof. Dr Roland Beisteiner, and Dr Henning Lohse-Busch (Rheintalklinik, Bad Krozingen).

• In this video Professor Beisteiner explains TPS®: https://www.tps-neuro.com/en/treatment